- $22.21m
- $7.62m
- $13.10m
- 65
- 63
- 14
- 45
R2019 June 30th | 2020 June 30th | 2021 June 30th | 2022 June 30th | 2023 June 30th | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
Standards: | USG | USG | USG | USG | USG |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 21.8 | 18.3 | 19.5 | 17.6 | 13.1 |
Cost of Revenue | |||||
Gross Profit | 6.82 | 5.66 | 6.73 | 6.62 | 4.46 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Total Operating Expenses | 21.6 | 18.8 | 19.4 | 16.2 | 38 |
Operating Profit | 0.276 | -0.484 | 0.116 | 1.41 | -24.9 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | 0.279 | -0.464 | 0.498 | 1.28 | 8.62 |
Provision for Income Taxes | |||||
Net Income After Taxes | 0.306 | -0.466 | 0.494 | 1.27 | 8.3 |
Net Income Before Extraordinary Items | |||||
Net Income | 0.306 | -0.466 | 0.494 | 1.27 | 8.3 |
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | 0.306 | -0.466 | 0.494 | 1.27 | 8.3 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | 0.041 | -0.063 | 0.017 | 0.077 | 0.851 |